G. Mithieux and A. Gautier-stein, Intestinal glucose metabolism revisited, Diabetes Res. Clin. Pract, vol.105, pp.295-301, 2014.

A. Penhoat, L. Fayard, A. Stefanutti, G. Mithieux, and F. Rajas, Intestinal gluconeogenesis is crucial to maintain a physiological fasting glycemia in the absence of hepatic glucose production in mice, Metabolism, vol.63, pp.104-111, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01859366

C. Gutierrez-repiso, S. Garcia-serrano, F. J. Moreno-ruiz, G. Alcain-martinez, F. Rodriguez-pacheco et al., Jejunal gluconeogenesis associated with insulin resistance level and its evolution after Roux-en-Y gastric bypass, Surg. Obes. Relat. Dis, vol.13, pp.623-630, 2017.

L. M. Federico, M. Naples, D. Taylor, and K. Adeli, Intestinal insulin resistance and aberrant production of apolipoprotein B48 lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia: Evidence for activation of protein tyrosine phosphatase-1B, extracellular signal-related kinase, and sterol regulatory element-binding protein-1c in the fructose-fed hamster intestine, Diabetes, vol.55, pp.1316-1326, 2006.

C. Gutierrez-repiso, F. Rodriguez-pacheco, J. Garcia-arnes, S. Valdés, M. Gonzalo et al., The expression of genes involved in jejunal lipogenesis and lipoprotein synthesis is altered in morbidly obese subjects with insulin resistance, Lab. Investig, vol.95, pp.1409-1417, 2015.

F. Soriguer, S. Garcia-serrano, L. Garrido-sanchez, C. G. Repiso, G. Rojo-martinez et al., Jejunal wall triglyceride concentration of morbidly obese persons is lower in those with type 2 diabetes mellitus, J. Lipid Res, vol.51, pp.3516-3523, 2010.

A. Ho-plagaro, C. Santiago-fernandez, S. García-serrano, C. Rodriguez, L. Garrido-sanchez et al., A lower duodenal immune response is associated with an increase of insulin resistance in patients with morbid obesity, Int. J. Obes, vol.2019, pp.1-13

G. Mithieux, F. Rajas, and A. Gautier-stein, A Novel Role for Glucose 6-Phosphatase in the Small Intestine in the Control of Glucose Homeostasis, J. Boil. Chem, vol.279, pp.44231-44234, 2004.

F. Rajas, N. Bruni, S. Montano, C. Zitoun, and G. Mithieux, The glucose-6 phosphatase gene is expressed in human and rat small intestine: Regulation of expression in fasted and diabetic rats, Gastroenterology, vol.117, pp.132-139, 1999.

Y. Yan, Z. Zhou, F. Kong, S. Feng, X. Li et al., Roux-en-Y Gastric Bypass Surgery Suppresses Hepatic Gluconeogenesis and Increases Intestinal Gluconeogenesis in a T2DM Rat Model, Obes. Surg, vol.26, pp.2683-2690, 2016.

S. Troy, M. Soty, L. Ribeiro, L. Laval, S. Migrenne et al., Intestinal Gluconeogenesis Is a Key Factor for Early Metabolic Changes after Gastric Bypass but Not after Gastric Lap-Band in Mice, Cell Metab, vol.8, pp.201-211, 2008.

T. A. Smith, Mammalian hexokinases and their abnormal expression in cancer, Br. J. Biomed. Sci, vol.57, pp.170-178, 2000.

N. Schormann, K. L. Hayden, P. Lee, S. Banerjee, and D. Chattopadhyay, An overview of structure, function, and regulation of pyruvate kinases, Protein Sci, vol.28, pp.1771-1784, 2019.

F. Renström, J. Burén, M. Svensson, and J. W. Eriksson, Insulin resistance induced by high glucose and high insulin precedes insulin receptor substrate 1 protein depletion in human adipocytes, Metabolism, vol.56, pp.190-198, 2007.

A. C. Thirone, C. Huang, and A. Klip, Tissue-specific roles of IRS proteins in insulin signaling and glucose transport, Trends Endocrinol. Metab, vol.17, pp.72-78, 2006.

S. M. Brachmann, K. Ueki, J. A. Engelman, R. C. Kahn, and L. C. Cantley, Phosphoinositide 3-Kinase Catalytic Subunit Deletion and Regulatory Subunit Deletion Have Opposite Effects on Insulin Sensitivity in Mice, Mol. Cell. Boil, vol.25, pp.1596-1607, 2005.

V. Saini, Molecular mechanisms of insulin resistance in type 2 diabetes mellitus, World J. Diabetes, vol.1, pp.68-75, 2010.

G. Mithieux, F. Rajas, and C. Zitoun, Glucose utilization is suppressed in the gut of insulin-resistant high fat-fed rats and is restored by metformin, Biochem. Pharmacol, vol.72, pp.198-203, 2006.

P. R. Shepherd, Mechanisms regulating phosphoinositide 3-kinase signalling in insulin-sensitive tissues, Acta Physiol. Scand, vol.183, pp.3-12, 2005.

J. B. Carvalheira, M. A. Torsoni, M. Ueno, M. E. Amaral, E. P. Araújo et al., Cross-Talk between the Insulin and Leptin Signaling Systems in Rat Hypothalamus, Obes. Res, vol.13, pp.48-57, 2005.

A. Nazarians-armavil, J. A. Menchella, and D. D. Belsham, Cellular Insulin Resistance Disrupts Leptin-Mediated Control of Neuronal Signaling and Transcription, Mol. Endocrinol, vol.27, pp.990-1003, 2013.

E. Garcia-fuentes, J. García-almeida, J. Garcia-arnes, J. Rivas-marín, J. Gallego-perales et al., Morbidly Obese Individuals with Impaired Fasting Glucose have a Specific Pattern of Insulin Secretion and Sensitivity: Effect of Weight Loss after Bariatric Surgery, Obes. Surg, vol.16, pp.1179-1188, 2006.

J. J. González-plaza, C. Santiago-fernandez, C. Gutierrez-repiso, S. García-serrano, F. Rodriguez-pacheco et al., The changes in the transcriptomic profiling of subcutaneous adipose tissue after bariatric surgery depend on the insulin resistance state, Surg. Obes. Relat. Dis, vol.14, pp.1182-1191, 2018.

M. Murri, E. García-fuentes, J. M. García-almeida, L. Garrido-sanchez, M. D. Mayas et al., Changes in Oxidative Stress and Insulin Resistance in Morbidly Obese Patients After Bariatric Surgery, Obes. Surg, vol.20, pp.363-368, 2009.

L. Garrido-sánchez, J. Vendrell, D. Fernández-garcía, V. Ceperuelo-mallafré, M. R. Chacón et al., De Novo Lipogenesis in Adipose Tissue Is Associated with Course of Morbid Obesity after Bariatric Surgery, PLoS ONE, vol.7, 2012.

, Enzymatic Activity of Glucose-6-Phosphatase, 2020.

P. Kovacs, R. L. Hanson, Y. Lee, X. Yang, S. Kobes et al., The role of insulin receptor substrate-1 gene (IRS1) in type 2 diabetes in Pima Indians, Diabetes, vol.52, pp.3005-3009, 2003.

X. Huang, A. Vaag, M. Hansson, and L. Groop, Down-regulation of insulin receptor substrates (IRS)-1 and IRS-2 and Src homologous and collagen-like protein Shc gene expression by insulin in skeletal muscle is not associated with insulin resistance or type 2 diabetes, J. Clin. Endocrinol. Metab, vol.87, pp.255-259, 2002.

F. Stümpel, R. Burcelin, K. Jungermann, and B. Thorens, Normal kinetics of intestinal glucose absorption in the absence of GLUT2: Evidence for a transport pathway requiring glucose phosphorylation and transfer into the endoplasmic reticulum, Proc. Natl. Acad. Sci, vol.98, pp.11330-11335, 2001.

A. Veilleux, E. Grenier, P. Marceau, A. C. Carpentier, D. Richard et al., Intestinal lipid handling: Evidence and implication of insulin signaling abnormalities in human obese subjects, Arterioscler. Thromb. Vasc. Biol, vol.34, pp.644-653, 2014.

E. Lefai, M. Roques, N. Vega, M. Laville, and H. Vidal, Expression of the splice variants of the p85alpha regulatory subunit of phosphoinositide 3-kinase in muscle and adipose tissue of healthy subjects and type 2 diabetic patients, Biochem. J, vol.360, pp.117-126, 2001.

F. Giorgino, M. T. Pedrini, L. Matera, and R. J. Smith, Specific increase in p85alpha expression in response to dexamethasone is associated with inhibition of insulin-like growth factor-I stimulated phosphatidylinositol 3-kinase activity in cultured muscle cells, J. Boil. Chem, vol.272, pp.7455-7463, 1997.

K. Ueki, D. A. Fruman, S. M. Brachmann, Y. Tseng, L. C. Cantley et al., Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signaling and survival, Mol. Cell. Boil, vol.22, pp.965-977, 2002.

T. Han, H. Xu, J. Li, L. Geng, X. Li et al., Leptin and its receptor in glucose metabolism of T-cell lymphoma, Oncol. Lett, vol.16, pp.5838-5846, 2018.

R. J. Coward, G. I. Welsh, J. Yang, C. Tasman, R. Lennon et al., The human glomerular podocyte is a novel target for insulin action, Diabetes, vol.54, pp.3095-3102, 2005.

P. Ebeling, H. A. Koistinen, and V. A. Koivisto, Insulin-independent glucose transport regulates insulin sensitivity, FEBS Lett, vol.436, pp.301-303, 1998.

I. Shimomura, R. E. Hammer, S. Ikemoto, M. S. Brown, and J. L. Goldstein, Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy, Nature, vol.401, pp.73-76, 1999.

J. Y. Jun, Z. Ma, R. Pyla, and L. Segar, Leptin treatment inhibits the progression of atherosclerosis by attenuating hypercholesterolemia in type 1 diabetic Ins2(+/Akita):apoE(-/-) mice, Atherosclerosis, vol.225, pp.341-347, 2012.

R. Sabino-silva, R. C. Mori, A. David-silva, M. M. Okamoto, H. S. Freitas et al., The Na(+)/glucose cotransporters: From genes to therapy. Braz, J. Med. Biol. Res, vol.43, pp.1019-1026, 2010.

K. Takata, T. Kasahara, M. Kasahara, O. Ezaki, and H. Hirano, Ultracytochemical localization of the erythrocyte/HepG2-type glucose transporter (GLUT1) in the ciliary body and iris of the rat eye, Investig. Ophthalmol. Vis. Sci, vol.32, pp.1659-1666, 1991.

A. A. Moghaddam, M. Woodward, and R. Huxley, Obesity and Risk of Colorectal Cancer: A Meta-analysis of 31 Studies with 70,000 Events, Cancer Epidemiol. Biomark. Prev, vol.16, pp.2533-2547, 2007.

K. Basen-engquist and M. Chang, Obesity and cancer risk: Recent review and evidence, Curr. Oncol. Rep, vol.13, pp.71-76, 2011.

M. Sung, J. Yeon, S. Park, J. H. Park, and M. Choi, Obesity-induced metabolic stresses in breast and colon cancer, Ann. N. Y. Acad. Sci, vol.1229, pp.61-68, 2011.

D. Wang, J. Chen, H. Chen, Z. Duan, Q. Xu et al., Leptin regulates proliferation and apoptosis of colorectal carcinoma through PI3K/Akt/mTOR signalling pathway, J. Biosci, vol.37, pp.91-101, 2012.